全文获取类型
收费全文 | 188340篇 |
免费 | 1854篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 1197篇 |
儿科学 | 7012篇 |
妇产科学 | 3380篇 |
基础医学 | 18024篇 |
口腔科学 | 1704篇 |
临床医学 | 14473篇 |
内科学 | 33429篇 |
皮肤病学 | 829篇 |
神经病学 | 17702篇 |
特种医学 | 9102篇 |
外科学 | 29913篇 |
综合类 | 2692篇 |
一般理论 | 18篇 |
预防医学 | 19957篇 |
眼科学 | 2976篇 |
药学 | 9994篇 |
中国医学 | 638篇 |
肿瘤学 | 17204篇 |
出版年
2023年 | 78篇 |
2022年 | 91篇 |
2021年 | 262篇 |
2020年 | 154篇 |
2019年 | 249篇 |
2018年 | 22173篇 |
2017年 | 17545篇 |
2016年 | 19694篇 |
2015年 | 1161篇 |
2014年 | 1181篇 |
2013年 | 1407篇 |
2012年 | 7834篇 |
2011年 | 21973篇 |
2010年 | 19290篇 |
2009年 | 11971篇 |
2008年 | 20348篇 |
2007年 | 22606篇 |
2006年 | 1449篇 |
2005年 | 3076篇 |
2004年 | 4256篇 |
2003年 | 5148篇 |
2002年 | 3245篇 |
2001年 | 372篇 |
2000年 | 497篇 |
1999年 | 290篇 |
1998年 | 399篇 |
1997年 | 345篇 |
1996年 | 215篇 |
1995年 | 217篇 |
1994年 | 197篇 |
1993年 | 149篇 |
1992年 | 107篇 |
1991年 | 143篇 |
1990年 | 185篇 |
1989年 | 145篇 |
1988年 | 109篇 |
1987年 | 83篇 |
1986年 | 74篇 |
1985年 | 81篇 |
1984年 | 84篇 |
1983年 | 101篇 |
1982年 | 97篇 |
1981年 | 77篇 |
1980年 | 102篇 |
1979年 | 50篇 |
1978年 | 60篇 |
1974年 | 50篇 |
1938年 | 60篇 |
1932年 | 57篇 |
1930年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
994.
995.
Assessment of DE-71, a commercial polybrominated diphenyl ether (PBDE) mixture, in the EDSP male and female pubertal protocols. 总被引:6,自引:0,他引:6
Tammy E Stoker Susan C Laws Kevin M Crofton Joan M Hedge Janet M Ferrell Ralph L Cooper 《Toxicological sciences》2004,78(1):144-155
DE-71, a commercial mixture, was used to test the sensitivity of the female and male pubertal protocol to detect thyroid active chemicals. These protocols are being evaluated for the U.S. EPA's Endocrine Disruptor Screening Program as part of a Tier I Screening Battery. To examine the ability of these protocols to screen for chemicals that induce the clearance of thyroid hormone, we examined male and female Wistar rats following DE-71 exposure. Rats were gavaged daily with 0, 3, 30, or 60 mg/kg DE in corn oil from postnatal day (PND) 23-53 in the male or PND 22-41 in the female. The temporal effects of DE-71 on liver enzymes and thyroid hormones were measured in another group of males and females following only 5 days of dosing (PND 21 to 26 in females and PND 23 to 28 in males). Serum T4 was significantly decreased at 30 and 60 mg/kg following the 5-day exposures and in the 21-day exposed females. Doses of 3, 30, and 60 mg/kg decreased T4 in 31-day exposed males. Serum T3 was decreased and TSH elevated by 30 and 60 mg/kg in the 31-day exposed males only. Decreased colloid area and increased follicular cell heights (indicative of the hypothyroid state) were observed in thyroids of the 60 mg/kg groups of 20- and 31-day exposed female and males. Increased liver-to-body weight ratios coincided with a significant induction of uridinediphosphate-glucuronosyltransferase (UDGPT; two to four-fold), and ethoxy- and pentoxy-resorufin-O-deethylase (EROD and PROD) at the two highest doses in all exposures. Of the androgen dependent tissues in the 31-day exposed males, seminal vesicle (SV) and ventral prostate (VP) weights were reduced at 60 mg/kg, while testes and epididymal weights were not affected. Preputial separation (PPS) was also significantly delayed by doses of 30 and 60 mg/kg. In the female, the 60 mg/kg dose also caused a significant delay in the age of vaginal opening. Based upon the thyroid hormone response data, this study provides evidence that the 31-day alternative Tier 1 male protocol is a more sensitive test protocol than the 5-day or female pubertal protocol for thyrotoxic agents that act via up-regulation of hepatic metabolism. This apparent greater sensitivity may be due a greater body burden attained following the longer dosing regimen as compared with that of the female protocol, or to gender specific differences in thyroid hormone metabolism. Also, the delay in PPS and reduction in SV and VP weights may indicate a modification or inhibition of endogenous androgenic stimulation directly by DE-71 or a secondary effect that occurs in response to a DE-induced change in thyroid hormones. 相似文献
996.
997.
998.
Metabolomics is one of the newer omics fields, and has enabled researchers to complement genomic and protein level analysis of disease with both semi-quantitative and quantitative metabolite levels, which are the chemical mediators that constitute a given phenotype. Over more than a decade, methodologies have advanced for both targeted (quantification of specific analytes) as well as untargeted metabolomics (biomarker discovery and global metabolite profiling). Untargeted metabolomics is especially useful when there is no a priori metabolic hypothesis. Liquid chromatography coupled to mass spectrometry (LC-MS) has been the preferred choice for untargeted metabolomics, given the versatility in metabolite coverage and sensitivity of these instruments. Resolving and profiling many hundreds to thousands of metabolites with varying chemical properties in a biological sample presents unique challenges, or pitfalls. In this review, we address the various obstacles and corrective measures available in four major aspects associated with an untargeted metabolomics experiment: (1) experimental design, (2) pre-analytical (sample collection and preparation), (3) analytical (chromatography and detection), and (4) post-analytical (data processing). 相似文献
999.
1000.
Hendrik Jürges 《The European journal of health economics》2017,18(2):195-208
As a result of strong financial incentives created by the German parental leave reform on January 1, 2007, some 1000 births have been shifted from the last days of 2006 to the first days of 2007, especially by working mothers. This fact is already described in the literature, yet there is no evidence as to the mechanisms and only scarce evidence regarding the effects on newborn health. I use new data to study the timing of C-sections and the induction of births around the day the reform took effect. I estimate that postponed C-sections and inductions account for nearly 80 % of the pre-reform shortfall and nearly 90 % of the post-reform excess number of births. Despite concerns voiced by doctors before the reform, hardly any evidence can be found for detrimental health effects of those shifts, as measured by changes in gestational age, birth weight, APGAR scores, neonatal mortality, or hospitalization. 相似文献